Sens. Hassan, Paul Press FDA to Increase Access to Life-Saving Naloxone
July 22, 2022
July 22, 2022
WASHINGTON, July 22 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release and letter:
Senators Maggie Hassan (D-NH) and Rand Paul (R-KY) are calling on the Food and Drug Administration (FDA) to increase access to naloxone, a life-saving drug that acts as an antidote for opioid overdoses. They are requesting that the FDA clarify regulations to ensure that public health organizations can obtain and distribute naloxone.
"As the ongoing opioid epide . . .
Senators Maggie Hassan (D-NH) and Rand Paul (R-KY) are calling on the Food and Drug Administration (FDA) to increase access to naloxone, a life-saving drug that acts as an antidote for opioid overdoses. They are requesting that the FDA clarify regulations to ensure that public health organizations can obtain and distribute naloxone.
"As the ongoing opioid epide . . .